Efficacy of Sotrastaurin Plus Tacrolimus After De Novo Kidney Transplantation: Randomized, Phase II Trial Results
Article first published online: 13 MAY 2013
© Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons
American Journal of Transplantation
Volume 13, Issue 7, pages 1746–1756, July 2013
How to Cite
Russ, G. R., Tedesco-Silva, H., Kuypers, D. R., Cohney, S., Langer, R. M., Witzke, O., Eris, J., Sommerer, C., von Zur-Mühlen, B., Woodle, E. S., Gill, J., Ng, J., Klupp, J., Chodoff, L. and Budde, K. (2013), Efficacy of Sotrastaurin Plus Tacrolimus After De Novo Kidney Transplantation: Randomized, Phase II Trial Results. American Journal of Transplantation, 13: 1746–1756. doi: 10.1111/ajt.12251
- Issue published online: 26 JUN 2013
- Article first published online: 13 MAY 2013
- Manuscript Accepted: 14 MAR 2013
- Manuscript Revised: 11 MAR 2013
- Manuscript Received: 14 JAN 2013
- Novartis Pharma AG
All Supplemental Data may be found in the online version of this article.
Table S1. (a) Summary statistics for sotrastaurin/MPA trough levels and (b) mean daily dose of steroids (safety population).
Table S2. Incidence of cardiac disorders (12 months, safety population).
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.